Note 1 This instrument is a standard under the Food Standards Australia New Zealand Act 1991 (Cth). The standards together make up the Australia New Zealand Food Standards Code. See also section 1.1.1—3.
Special purpose foods are regulated by Part 9 of Chapter 2, which contains Standard 2.9.1, Standard 2.9.2, Standard 2.9.3, Standard 2.9.4, Standard 2.9.5 and Standard 2.9.6. This Standard prescribes information for these standards.
Note 2 The provisions of the Code that apply in New Zealand are incorporated in, or adopted under, the Food Act 2014 (NZ). See also section 1.1.1—3.
S29—1 Name
This Standard is Australia New Zealand Food Standards Code – Schedule 29 – Special purpose foods.
Note Commencement:
This Standard commences on 1 March 2016, being the date specified as the commencement date in notices in the Gazette and the New Zealand Gazette under section 92 of the Food Standards Australia New Zealand Act 1991 (Cth). See also section 93 of that Act.
S29—2 Infant formula products—calculation of energy content
(1) For paragraph 2.9.1—4(2)(a), the energy content of infant formula product must be calculated using:
(a) the energy contributions of the following *components only:
(i) fat; and
(ii) protein; and
(iii) carbohydrate; and
(b) the relevant energy factors set out in section S11—2.
(2) The energy content of an infant formula product must be expressed in kilojoules.
S29—2A Infant formula products—calculation of protein content
For paragraph 2.9.1—4(2)(b), the protein content of infant formula product must be calculated by multiplying the nitrogen content of the product by a nitrogen‑to‑protein conversion factor of 6.25.
S29—2B Infant formula products—calculation of vitamin A content
For paragraph 2.9.1—4(2)(c), the vitamin A content of infant formula products must be calculated using only the retinol forms of vitamin A prescribed in Column 1 of Table S29—23.
S29—3 Infant formula products—L-amino acids that must be present
For subsection 2.9.1—6(5) and section 2.9.1—33, the table is:
L-amino acids that must be present in infant formula products
L-amino acid
Minimum amount per 100 kJ
Cysteine
9 mg
Histidine
10 mg
Section 1 - Australia New Zealand Food Standards Code – Schedule 29 – Special purpose foods - Australia New Zealand Food Standards Code – Schedule 29 – Special purpose foods | Zoe
Isoleucine
22 mg
Leucine
40 mg
Lysine
27 mg
Methionine
6 mg
Phenylalanine
19 mg
Threonine
18 mg
Tryptophan
8 mg
Tyrosine
18 mg
Valine
22 mg
S29—4 Infant formula products—limits on fatty acids
For paragraphs 2.9.1—7(1)(g) and 2.9.1—34(1)(g), the table is:
Limits on fatty acids that may be present in infant formula products
Column 1
Column 2
Substance
Maximum amountper 100 kJ
Docosahexaenoic acid
12 mg
Total trans fatty acids
Not more than 4% of the total fatty acids
Erucic acid (22:1)
Not more than 1% of the total fatty acids
S29—5 Vitamins, minerals, electrolytes and other substances required in infant formula and special medical purpose product for infants
For sections 2.9.1—7(2)(b)(i), 2.9.1—8(1), 2.9.1—34(2)(b) and 2.9.1—36(1), the table is:
Vitamins, minerals, electrolytes and other nutritive substances required in infant formula and special medical purpose product for infants
Note It is recommended that infant formula and a special medical purpose product for infants contain a substance listed in Column 1 of the table in an amount that is not more than the amount (if any) specified for that substance in Column 4 of the table. The amounts specified in Column 4 are Guidance Upper Levels and are recommended upper levels for nutrients which pose no significant risks on the basis of current scientific knowledge. These levels are values derived on the basis of meeting nutritional requirements of infants and an established history of apparent safe use. These Guidance Upper Levels should not be exceeded unless higher nutrient levels cannot be avoided due to high or variable contents in constituents of infant formulas or special medical purpose product for infants; or due to technological reasons.
S29—6 Vitamins, minerals and electrolytes required in follow-on formula
For subparagraph 2.9.1—7(2)(b)(ii) and subsection 2.9.1—8(2), the table is:
Vitamins, minerals and electrolytes required in follow-on formula
Column 1
Column 2
Column 3
Column 4
Vitamin, mineral or electrolyte
Minimum amountper 100 kJ
Maximum amountper 100 kJ
Guidance upper levelper 100 kJ (see Note)
Vitamins
Vitamin A
14 μg RE
43 μg RE
Vitamin D
0.24 μg
0.72 μg
Vitamin C
1.7 mg
17 mg
Thiamin
10 μg
72 µg
Riboflavin
14.3 μg
120 µg
Niacin
72 μg
359 µg
Vitamin B6
8 μg
42 µg
Folic acid
2.4 μg
12 µg
Pantothenic acid
96 μg
478 µg
Vitamin B12
0.02 μg
0.36 µg
Biotin
0.24 μg
2.4 µg
Vitamin E
0.14 mg α-TE
1.2 mg α-TE
Vitamin K
0.24 μg
6 µg
Minerals
Calcium
12 mg
43 mg
Phosphorus
6 mg
24 mg
Magnesium
1.2 mg
3.6 mg
Iron
0.24 mg
0.48 mg
Iodine
2.4 μg
14 µg
Copper
8 μg
29 µg
Zinc
0.12 mg
0.36 mg
Manganese
0.24 μg
24 μg
Selenium
0.48 μg
2.2 µg
Electrolytes
Chloride
12 mg
38 mg
Sodium
4.8 mg
14 mg
Potassium
14 mg
43 mg
Note It is recommended that follow-on formula contain a substance listed in Column 1 of the table in an amount that is not more than the amount (if any) specified for that substance in column 4 of the table. The amounts specified are Guidance Upper Levels and are recommended upper levels for nutrients which pose no significant risks on the basis of current scientific knowledge. These levels are values derived on the basis of meeting nutritional requirements of infants and an established history of apparent safe use. The Guidance Upper Levels should not be exceeded unless higher nutrient levels cannot be avoided due to high or variable contents in constituents of follow-on formula or due to technological reasons.
S29—7 Optional nutritive substances in infant formula and special medical purpose product for infants
For subsection 2.9.1—9(1) and section 2.9.1—37, the table is set out below.
Optional nutritive substances in infant formula and special medical purpose product for infants
Column 1
Column 2
Column 3
Substance
Minimum amount per 100 kJ
Maximum amount per 100 kJ
2′-fucosyllactose permitted for use by Standard 1.5.2
96 mg
3-fucosyllactose permitted for use by Standard 1.5.2
80 mg
3′-sialyllactose sodium salt permitted for use by Standard 1.5.2
8 mg
6′-sialyllactose sodium salt permitted for use by Standard 1.5.2
16 mg
A combination of 2′-fucosyllactose and difucosyllactose, permitted for use by Standard 1.5.2
96 mg
A combination of: 2′-fucosyllactose permitted for use by Standard 1.5.2; and lacto-N-neotetraose permitted for use by Standard 1.5.2
96 mg which contains not more than 24 mg of lacto-N-neotetraose
Adenosine-5′-monophosphate
0.36 mg
Cytidine-5′-monophosphate
0.6 mg
Guanosine-5′monophosphate
0.4 mg
Inosine-5′-monophosphate
0.24 mg
Lactoferrinlacto-N-tetraose permitted for use by Standard 1.5.2
40 mg32 mg
Lutein
1.5 µg
5 µg
Milk fat globule membrane-enriched whey protein concentrate
0.14 g
0.28 g
Taurine
2.9 mg
Uridine-5′-monophosphate
0.42 mg
S29—8 Optional nutritive substances in follow-on formula
For subsection 2.9.1—9(2), the table is set out below.
Optional nutritive substances in follow-on formula
Column 1
Column 2
Column 3
Column 4
Substance
Minimum amount per 100 kJ
Maximum amount per 100 kJ
Guidance upper level per 100 kJ (see Note)
2′-fucosyllactose permitted for use by Standard 1.5.2
96 mg
3-fucosyllactose permitted for use by Standard 1.5.2
80 mg
3′-sialyllactose sodium salt permitted for use by Standard 1.5.2
8 mg
6′-sialyllactose sodium salt permitted for use by Standard 1.5.2
16 mg
A combination of 2′-fucosyllactose and difucosyllactose, permitted for use by Standard 1.5.2
96 mg
A combination of: 2′-fucosyllactose permitted for use by Standard 1.5.2; and lacto-N-neotetraose permitted for use by Standard 1.5.2
96 mg which contains not more than 24 mg of lacto-N-neotetraose
Adenosine-5′-monophosphate
0.36 mg
L-carnitine
0.3 mg
Choline
12 mg
Cytidine-5′-monophosphate
0.6 mg
Guanosine-5′-monophosphate
0.4 mg
Inosine-5′-monophosphate
0.24 mg
Lactoferrin
40 mg
lacto-N-tetraose permitted for use by Standard 1.5.2
32 mg
Lutein
1.5 µg
5 µg
Milk fat globule membrane-enriched whey protein concentrate
0.14 g
0.28 g
Inositol
10 mg
Taurine
2.9 mg
Uridine-5′-monophosphate
0.42 mg
Note It is recommended that follow-on formula contain a substance listed in Column 1 of the table in an amount that is not more than the amount (if any) specified for that substance in Column 4 of the table. The amounts specified in Column 4 are Guidance Upper Levels and are recommended upper levels for nutrients which pose no significant risks on the basis of current scientific knowledge. These levels are values derived on the basis of meeting nutritional requirements of infants and an established history of apparent safe use. The Guidance Upper Levels should not be exceeded unless higher nutrient levels cannot be avoided due to high or variable contents in constituents of follow-on formula or due to technological reasons.
S29—9 Permitted forms of nutritive substances in infant formula products
For paragraphs 2.9.1—10(b) and 2.9.1—38(b), the table is set out below.
Permitted forms for nutritive substances used in infant formula products
Substance
Permitted forms
2′-fucosyllactose permitted for use by Standard 1.5.2
2′-fucosyllactose
3-fucosyllactose permitted for use by Standard 1.5.2
3-fucosyllactose
3′-sialyllactose sodium salt permitted for use by Standard 1.5.2
3′-sialyllactose sodium salt
6'-sialyllactose sodium salt permitted for use by Standard 1.5.2
6'-sialyllactose sodium salt
A combination of 2′-fucosyllactose and difucosyllactose, permitted for use by Standard 1.5.2
2'-fucosyllactose and difucosyllactose
A combination of: 2′-fucosyllactose permitted for use by Standard 1.5.2; and lacto-N-neotetraose permitted for use by Standard 1.5.2
2′-fucosyllactose and lacto-N-neotetraose
Adenosine-5′-monophosphate
Adenosine-5′- monophosphate
L-carnitine
L-carnitine
L-carnitine hydrochloride
L-carnitine tartrate
Choline
Choline chloride
Choline bitartrate
Choline
Choline citrate
Choline hydrogen tartrate
Cytidine-5′-monophosphate
Cytidine-5′-monophosphate
Guanosine-5′-monophosphate
Guanosine-5′-monophosphate
Guanosine-5′-monophosphate sodium salt
Inosine-5′-monophosphate
Inosine-5′-monophosphate
Inosine-5′-monophosphate sodium salt
Lactoferrin
Bovine lactoferrin
lacto-N-tetraose permitted for use by Standard 1.5.2
lacto-N-tetraose
Lutein
Lutein from Tagetes erecta L.
Milk fat globule membrane-enriched whey protein concentrate
Bovine milk fat globule membrane-enriched whey protein concentrate
Inositol
Myo-inositol
Taurine
Taurine
Uridine-5′-monophosphate
Uridine-5′-monophosphate sodium salt
Note Section S29—23 lists the permitted forms of vitamins, minerals and electrolytes in infant formula products.
S29—9A Infant formula products—conditions on use of permitted nutritive substances
The table for this section is as follows:
Conditions of use for permitted nutritive substances
Column 1
Column 2
Column 3
Substance
Permitted Form
Conditions of use
Lactoferrin
Bovine lactoferrin
During the exclusive use period, may only be sold under the brand Synlait for *use as a nutritive substance in an infant formula product.For the purposes of condition 1 above, exclusive use period means the period commencing on the date of gazettal of the Food Standards (Application A1253 – Bovine Lactoferrin in Infant Formula Products) Variation and ending 15 months after that date.
Milk fat globule membrane-enriched whey protein concentrate
Bovine milk fat globule membrane-enriched whey protein concentrate
1. During the exclusive use period, may only be sold under the brand Lacprodan® MFGM-10 for *use as a nutritive substance in an infant formula product.2. For the purposes of condition 1 above, exclusive use period means the period commencing on the date of gazettal of the Food Standards (Application A1307 – Milk fat globule membrane as a nutritive substance in infant formula products) Variation and ending 15 months after that date.
S29—10 Required format for a nutrition information statement
Entries and amounts for the following need only be included when stated in accordance with subsection 2.9.1—24(4), 2.9.1—24(5) and paragraph 2.9.1—25(6)(d): whey; casein; docosahexaenoic acid; eicosapentaenoic acid; arachidonic acid.
The heading ‘Other nutrients’ need only be included when required by subparagraph 2.9.1—25(2)(d)(ii) and paragraph 2.9.1—25(4)(a).
The heading ‘Long chain polyunsaturated fatty acids’ need only be included when required by paragraph 2.9.1—25(6)(a).
Entries and amounts for choline, inositol, L-carnitine are included under the heading ‘Other nutrients’ when required by paragraph 2.9.1—25(4)(a) and under the heading ‘Additional’ when required by paragraph 2.9.1—25(4)(b).
S29—10A Example of a nutrition information statement including quantities expressed as sold
For subsection 2.9.1—25(7), an example nutrition information statement including information expressed in accordance with subsection 2.9.1—24(7) is:
S29—11 Food for infants—claims that can be made about vitamins and minerals added to cereal-based food for infants
For section 2.9.2—10, the table is:
Claims that can be made about vitamins and minerals added to cereal-based food for infants
Vitamin or mineral
Maximum claim per serve
Thiamin (mg)
15% RDI
Niacin (mg)
15% RDI
Folate (μg)
10% RDI
Vitamin B6 (mg)
10% RDI
Vitamin C (mg)
10% RDI
Magnesium (mg)
15% RDI
S29—12 Formulated meal replacements—vitamins and minerals that must be present in formulated meal replacements
(1) For sections 2.9.3—3, 2.9.3—4 and 2.9.6—4, the table is set out below.
(2) In the table, the amounts set out in columns 2 and 3 are for a 1-meal serving, and are expressed as a proportion of the RDI.
Vitamins and minerals that must be present in formulated meal replacements
Column 1
Column 2
Column 3
Vitamin or mineral
Maximum amount
Maximum claim
Vitamin A
300 μg (40%)
300 μg (40%)
Thiamin
No amount set
0.55 mg (50%)
Riboflavin
No amount set
0.85 mg (50%)
Niacin
No amount set
5 mg (50%)
Folate
No amount set
100 μg (50%)
Vitamin B6
No amount set
0.8 mg (50%)
Vitamin B12
No amount set
1 μg (50%)
Vitamin C
No amount set
20 mg (50%)
Vitamin D
5.0 μg (50%)
5 μg (50%)
Vitamin E
No amount set
5 mg (50%)
Calcium
No amount set
400 mg (50%)
Iodine
75 μg (50%)
75 μg (50%)
Iron
No amount set
4.8 mg (40%)
Magnesium
No amount set
160 mg (50%)
Phosphorus
No amount set
500 mg (50%)
Zinc
No amount set
4.8 mg (40%)
S29—13 Vitamins and minerals that may be added to formulated meal replacements
(1) For sections 2.9.3—3, 2.9.3—4 and 2.9.6—4, the table is set out below.
(2) In the table, the amounts set out in columns 2 and 3 are for a 1-meal serving, and are expressed as a proportion of the *ESADDI unless stated otherwise.
Vitamins and minerals that may be added to formulated meal replacements
Column 1
Column 2
Column 3
Vitamin or mineral
Maximum amount
Maximum claim
Biotin
No amount set
5 μg (17%)
Pantothenic acid
No amount set
0.8 mg (17%)
Vitamin K
No amount set
40 μg (50%)
Chromium:
inorganic
34 μg (17%)
34 μg (17%)
organic
16 μg (8%)
no claim permitted
Copper:
inorganic
0.50 mg (17%)
0.50 mg (17%)
organic
0.24 mg (8%)
no claim permitted
Manganese:
inorganic
0.85 mg (17%)
0.85 mg (17%)
organic
0.4 mg (8%)
no claim permitted
Molybdenum:
inorganic
42.5 μg (17%)
42.5 μg (17%)
organic
20 μg (8%)
no claim permitted
Selenium:
inorganic
17.5 μg (25% RDI)
17.5 μg (25% RDI)
organic
9 μg (13% RDI)
9 μg (13% RDI)
S29—14 Vitamins and minerals that may be added to formulated supplementary foods
(1) For sections 2.9.3—5 and 2.9.3—6, the table is set out below.
(2) In the table, the amounts set out in Columns 2 and 3 are for a serving, and are expressed as a proportion of the RDI.
Vitamins and minerals that may be added to formulated supplementary foods
Column 1
Column 2
Column 3
Vitamin or mineral
Maximum amount
Maximum claim
Vitamins
Vitamin A
340 μg (45%)
265 μg (35%)
Thiamin
No amount set
0.55 mg (50%)
Riboflavin
No amount set
0.85 mg (50%)
Niacin
No amount set
5 mg (50%)
Folate
No amount set
100 μg (50%)
Vitamin B6
No amount set
0.8 mg (50%)
Vitamin B12
No amount set
1 μg (50%)
Vitamin C
No amount set
20 mg (50%)
Vitamin D
5 μg (50%)
5 μg (50%)
Vitamin E
No amount set
5 mg (50%)
Minerals
Calcium
No amount set
400 mg (50%)
Iodine
75 μg (50%)
75 μg (50%)
Iron
No amount set
6 mg (50%)
Magnesium
No amount set
130 mg (40%)
Phosphorus
No amount set
500 mg (50%)
Zinc
No amount set
3 mg (25%)
S29—15 Vitamins and minerals that may be added to formulated supplementary food for young children
(1) For sections 2.9.3—7 and 2.9.3—8, the table is set out below.
(2) In the table, the amounts set out in Columns 2 and 3 are for a serving, and are expressed as a proportion of the RDI.
Vitamins and minerals that may be added to formulated supplementary food for young children
Column 1
Column 2
Column 3
Vitamin or mineral
Maximum amount (as percentage of RDI)
Maximum claim (as percentage of RDI)
Vitamins
Vitamin A
135 μg (45%)
105 μg (35%)
Thiamin
No amount set
0.25 mg (50%)
Riboflavin
No amount set
0.4 mg (50%)
Niacin
No amount set
2.5 mg (50%)
Folate
No amount set
50 μg (50%)
Vitamin B6
No amount set
0.35 mg (50%)
Vitamin B12
No amount set
0.5 μg (50%)
Vitamin C
No amount set
15 mg (50%)
Vitamin D
2.5 μg (50%)
2.5 μg (50%)
Vitamin E
No amount set
2.5 mg (50%)
Minerals
Calcium
No amount set
350 mg (50%)
Iodine
70 μg (100%)
35 μg (50%)
Iron
No amount set
3.0 mg (50%)
Magnesium
No amount set
32 mg (40%)
Phosphorus
No amount set
250 mg (50%)
Zinc
No amount set
1.1 mg (25%)
S29—16 Vitamins and minerals that may be added to formulated supplementary sports foods
(1) For section 2.9.4—3, the table is set out below.
(2) In the table, the amounts set out in Columns 2 and 3 are for a *one-day quantity.
Vitamins and minerals that may be added to formulated supplementary sports foods
Column 1
Column 2
Column 3
Vitamin or mineral
Maximum amount
Maximum claim
Vitamins
Vitamin A
375 μg
375 μg
Thiamin
2.2 mg
Riboflavin
3.4 mg
Niacin
20 mg
Folate
400 μg
Vitamin B6
3.2 mg
Vitamin B12
4 μg
Vitamin C
80 mg
Vitamin D
2.5 μg
2.5 μg
Vitamin E
20 mg
Biotin
50 μg
Pantothenic acid
3.5 mg
Minerals
Calcium
1 600 mg
Chromium:
inorganic forms
100 μg
100 μg
organic forms
50 μg
50 μg
Copper:
inorganic forms
1.5 mg
1.5 mg
organic forms
750 μg
750 μg
Iodine
75 μg
75 μg
Iron
12 mg
Magnesium
640 mg
Manganese:
inorganic forms
2.5 mg
organic forms
1.25 mg
Molybdenum:
inorganic forms
125 μg
organic forms
62.5 μg
Phosphorus
1 000 mg
Selenium:
inorganic forms
52 μg
52 μg
organic forms
26 μg
26 μg
Zinc
12 mg
S29—17 Additional permitted forms for vitamins and minerals in formulated supplementary sports foods and in formulated meal replacements
For sections 2.9.3—3 and 2.9.4—3, the table is:
Additional permitted forms
Column 1
Column 2
Vitamin or mineral
Permitted forms
Biotin
d-biotin
Pantothenic acid
d-sodium pantothenate
Calcium
Calcium hydroxide
Chromium:
inorganic forms
Chromic chloride
organic forms
High chromium yeast
Chromium picolinate
Chromium nicotinate
Chromium aspartate
Copper:
inorganic forms
Cupric carbonate
Cupric sulphate
organic forms
Copper gluconate
Copper-lysine complex
Cupric citrate
Magnesium
Magnesium citrate
Magnesium hydroxide
Manganese:
inorganic forms
Manganese carbonate
Manganese chloride
Manganese sulphate
organic forms
Manganese citrate
Molybdenum:
inorganic forms
Sodium molybdate
organic forms
High molybdenum yeast
Phosphorus
Magnesium phosphate, monobasic
Potassium phosphate, tribasic
Sodium phosphate, monobasic
Sodium phosphate, tribasic
Phosphoric acid
S29—18 Amino acids that may be added to formulated supplementary sports food
For paragraph 2.9.4—3(1)(b), the table is.
Amino acids that may be added to formulated supplementary sports food
Column 1
Column 2
Amino acid
Maximum amount that may be added to a one-day quantity
L-Alanine
1 200 mg
L-Arginine
1 100 mg
L-Aspartic acid
600 mg
L-Cysteine
440 mg
L-Glutamine
1 900 mg
L-Glutamic acid
1 600 mg
Glycine
1 500 mg
L-Histidine
420 mg
L-Isoleucine
350 mg
L-Leucine
490 mg
L-Lysine
420 mg
L-Methionine
180 mg
L-Ornithine
360 mg
L-Phenylalanine
490 mg
L-Proline
1 100 mg
L-Serine
1 400 mg
L-Taurine
60 mg
L-Threonine
245 mg
L-Tyrosine
400 mg
L-Tryptophan
100 mg
L-Valine
350 mg
S29—19 Substances that may be used as nutritive substances in formulated supplementary sports food
For paragraph 2.9.4—3(1)(c), the table is:
Substances that may be used as nutritive substances in formulated supplementary sports food
Column 1
Column 2
Substance
Maximum amount that may be added to a one-day quantity
L-carnitine
2g
Choline
10 mg
Inosine
10 mg
Ubiquinones
15 mg
Creatine
3 g
Gamma-oryzinol
25 mg
S29—20 Substances that may be added to food for special medical purposes
For section 2.9.5—6, the table is.
Substances that may be added to food for special medical purposes
Sodium, potassium, calcium, magnesium salts of single amino acids listed in this section
Hydrochlorides of single amino acids listed in this section
L-alanine
L-arginine
L-arginine acetate
L-asparagine
L-aspartic acid
L-citrulline
L-cysteine
L-cystine
L-glutamic acid
L-glutamine
Glycine
L-histidine
L-isoleucine
L-leucine
L-lysine
L-lysine acetate
L-methionine
L-ornithine
L-phenylalanine
L-proline
L-serine
L-threonine
L-tyrosine
L-tryptophan
L-valine
L-arginine-L-aspartate
L-lysine-L-aspartate
L-lysine-L-glutamate
N-acetyl-L-methionine
Carnitine
L-carnitine
L-carnitine hydrochloride
L-carnitine L-tartrate
Choline
Choline
Choline bitartrate
Choline chloride
Choline citrate
Choline hydrogen tartrate
Inositol
Inositol
Nucleotides
Adenosine-5′-monophosphate
Adenosine-5′-monophosphate sodium salt
Cytidine-5′-monophosphate
Cytidine-5′-monophosphate sodium salt
Guanosine-5′-monophosphate
Guanosine-5′-monophosphate sodium salt
Inosine-5′-monophosphate
Inosine-5′-monophosphate sodium salt
Uridine-5′-monophosphate
Uridine-5′-monophosphate sodium salt
Taurine
Taurine
S29—21 Amounts of nutrients for food for special medical purposes represented as a sole source of nutrition
For section, 2.9.5—7, the table is:
Amounts of nutrients for food for special medical purposes represented as a sole source of nutrition
Column 1
Column 2
Column 3
Nutrient
Minimum amount per MJ
Maximum amount per MJ
Vitamins
Vitamin A
84 µg retinol equivalents1
430 µg retinol equivalents1
Thiamin
0.15 mg
No maximum set
Riboflavin
0.2 mg
No maximum set
Niacin
2.2 mg niacin equivalents2
No maximum set
Vitamin B6
0.2 mg
1.2 mg
Folate
25 µg
No maximum set
Vitamin B12
0.17 µg
No maximum set
Vitamin C
5.4 mg
No maximum set
Vitamin D
(a) for products intended for children aged 1–10 years—
1.2 µg
7.5 µg
(b) otherwise—
1.2 µg
6.5 µg
Vitamin E
1 mg alpha-tocopherol equivalents3
No maximum set
Biotin
1.8 µg
No maximum set
Pantothenic Acid
0.35 mg
No maximum set
Vitamin K
8.5 µg
No maximum set
Minerals
Calcium
(a) for products intended for children aged 1–10 years—
120 mg
600 mg
(b) otherwise—
84 mg
420 mg
Magnesium
18 mg
No maximum set
Iron
1.2 mg
No maximum set
Phosphorus
72 mg
No maximum set
Zinc
1.2 mg
3.6 mg
Manganese
0.12 mg
1.2 mg
Copper
0.15 mg
1.25 mg
Iodine
15.5 µg
84 µg
Chromium
3 µg
No maximum set
Molybdenum
7 µg
No maximum set
Selenium
6 µg
25 µg
Electrolytes
Sodium
72 mg
No maximum set
Potassium
190 mg
No maximum set
Chloride
72 mg
No maximum set
Note 1 See paragraph 1.1.2—14(3)(a).
Note 2 For niacin, add niacin and any niacin provided from the conversion of the amino acid tryptophan, using the conversion factor 1:60.
Note 3 See paragraph 1.1.2—14(3)(c).
S29—22 Nutritional content requirements for a very low energy diet
For paragraph 2.9.5—18(1)(f), the table is:
Amounts of nutrients in a very low energy diet
Column 1
Column 2
Nutrient
Minimum amount per daily intake
Vitamins
Vitamin A
600 µg retinol equivalents1
Vitamin D
2.5 µg
Vitamin E
10 mg α-tocopherol equivalents2
Vitamin C
30 mg
Vitamin B6
2 mg
Vitamin B12
1 µg
Niacin
11 mg niacin equivalents3
Riboflavin
1.2 mg
Thiamin
0.8 mg
Folic Acid
200 µg
Minerals
CalciumPhosphorusIronIodineMagnesium
500 mg500 mg16 mg140 µg350 mg
CopperZincPotassiumSodium
1.5 mg6 mg1.6 g1 g
Note 1 See paragraph 1.1.2—14(3)(a).
Note 2 See paragraph 1.1.2—14(3)(c).
Note 3 For niacin, add niacin and any niacin provided from the conversion of the amino acid tryptophan, using the conversion factor 1:60.
S29—23 Permitted forms of vitamins, minerals and electrolytes in infant formula products, food for infants, formulated meal replacements (vitamin K) and food for special medical purposes
For sections 2.9.1—10(a), 2.9.1—38(a), 2.9.2—4, 2.9.2—5, 2.9.2—6, 2.9.3—3(2)(c)(iii) and 2.9.5—6, the table is:
Permitted forms of vitamins, minerals and electrolytes in infant formula products, food for infants, formulated meal replacements (vitamin K) and food for special medical purposes
Vitamin, mineral or electrolyte
Permitted forms
Vitamin A
Retinol forms
vitamin A (retinol)
vitamin A acetate (retinyl acetate)
vitamin A palmitate (retinyl palmitate)
retinyl propionate
Provitamin A forms
beta-carotene
Vitamin C
L-ascorbic acid
L-ascorbyl palmitate
calcium ascorbate
potassium ascorbate
sodium ascorbate
Vitamin D
vitamin D2 (ergocalciferol)
vitamin D3 (cholecalciferol)
vitamin D (cholecalciferol-cholesterol)
Thiamin
thiamin hydrochloride
thiamin mononitrate
Riboflavin
riboflavin
riboflavin-5′-phosphate, sodium
Niacin
niacinamide (nicotinamide)
Vitamin B6
pyridoxine hydrochloride
pyridoxine-5′-phosphate
Folate
Folic acid
Pantothenic acid
calcium pantothenate
dexpanthenol
D-panthenol
calcium D-pantothenate
sodium D-pantothenate
Vitamin B12
cyanocobalamin
hydroxocobalamin
Biotin
d-biotin
Vitamin E
dl-α-tocopherol
d-α-tocopherol concentrate
tocopherols concentrate, mixed
d-α-tocopheryl acetate
dl-α-tocopheryl acetate
d-α-tocopheryl acid succinate
dl-α-tocopheryl succinate
Vitamin K
Vitamin K1 as phylloquinone (phytonadione)
Calcium
calcium carbonate
calcium chloride
calcium citrate
calcium gluconate
calcium glycerophosphate
calcium hydroxide
calcium lactate
calcium oxide
calcium phosphate, dibasic
calcium phosphate, monobasic
calcium phosphate, tribasic
calcium sulphate
Chloride
calcium chloride
magnesium chloride
potassium chloride
sodium chloride
Chromium
chromium sulphate
Copper
copper gluconate
cupric sulphate
cupric citrate
cupric carbonate
Iodine
potassium iodate
potassium iodide
sodium iodide
Iron
ferric ammonium citrate
ferric citrate
ferric pyrophosphate
ferrous bisglycinate
ferrous citrate
ferrous fumarate
ferrous gluconate
ferrous lactate
ferrous succinate
ferrous sulphate
Magnesium
magnesium carbonate
magnesium chloride
magnesium gluconate
magnesium oxide
magnesium phosphate, dibasic
magnesium phosphate, tribasic
magnesium sulphate
magnesium hydroxide carbonate
magnesium hydroxide
magnesium salts of citric acid
Manganese
manganese carbonate
manganese chloride
manganese citrate
manganese gluconate
manganese sulphate
Molybdenum
sodium molybdate VI
Phosphorus
calcium glycerophosphate
calcium phosphate, dibasic
calcium phosphate, monobasic
calcium phosphate, tribasic
magnesium phosphate, dibasic
potassium phosphate, dibasic
potassium phosphate, monobasic
potassium phosphate, tribasic
sodium phosphate, dibasic
sodium phosphate, monobasic
sodium phosphate, tribasic
Potassium
potassium bicarbonate
potassium carbonate
potassium chloride
potassium citrate
potassium glycerophosphate
potassium gluconate
potassium hydroxide
potassium phosphate, dibasic
potassium phosphate, monobasic
potassium phosphate, tribasic
potassium L-lactate
Selenium
seleno methionine
sodium selenate
sodium selenite
Sodium
sodium bicarbonate
sodium carbonate
sodium chloride
sodium chloride iodised
sodium citrate
sodium gluconate
sodium hydroxide
sodium iodide
sodium lactate
sodium phosphate, dibasic
sodium phosphate, monobasic
sodium phosphate, tribasic
sodium sulphate
sodium tartrate
Zinc
zinc acetate
zinc chloride
zinc citrate (zinc citrate dihydrate or zinc citrate trihydrate)
zinc gluconate
zinc lactate
zinc oxide
zinc sulphate
Application, saving and transitional provisions
The table below details information on application, saving or transitional provisions in instruments affecting this Standard.
<table cellspacing="0" cellpadding="0" style="width:455.1pt; border-collapse:collapse"><tbody><tr style="height:23.45pt"><td style="width:41.35pt; border-top:0.75pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="margin-bottom:2pt; font-size:8pt"><span style="font-weight:bold">Instrument items affected</span></p></td><td style="width:27.15pt; border-top:0.75pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="margin-bottom:2pt; font-size:8pt"><span style="font-weight:bold">A’ment No.</span></p></td><td style="width:50pt; border-top:0.75pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="margin-bottom:2pt; font-size:8pt"><span style="font-weight:bold">FRLI registration</span></p><p style="margin-bottom:2pt; font-size:8pt"><span style="font-weight:bold">Gazette</span></p></td><td style="width:57pt; border-top:0.75pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="margin-bottom:2pt; font-size:8pt"><span style="font-weight:bold">Instrument’s transitional provision</span></p></td><td style="width:228.35pt; border-top:0.75pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="margin-bottom:2pt; font-size:8pt"><span style="font-weight:bold">Description of transitional arrangement</span></p></td></tr><tr style="height:14.15pt"><td colspan="5" style="width:444.25pt; border-top:0.75pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:middle"><p style="margin-bottom:2pt; font-size:9pt"><span style="font-weight:bold; font-style:italic">Food Standards (Application A1230 – Very Low Energy Diets (VLED)) Variation</span></p></td></tr><tr style="height:23.45pt"><td style="width:41.35pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="margin-bottom:2pt; font-size:8pt"><span>Item [4.1] of the Schedule</span></p></td><td style="width:27.15pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="margin-bottom:2pt; font-size:8pt"><span>208</span></p></td><td style="width:50pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="margin-left:5.65pt; text-indent:-5.65pt; font-size:8pt"><span>F2022L00733</span></p><p style="margin-left:5.65pt; text-indent:-5.65pt; font-size:8pt"><span>1 June 2022</span></p><p style="margin-left:5.65pt; text-indent:-5.65pt; font-size:8pt"><span>FSC 148</span></p><p style="margin-bottom:2pt; font-size:8pt"><span>1 June 2022</span></p></td><td style="width:57pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="margin-left:5.65pt; text-indent:-5.65pt; font-size:8pt"><span>Clause 4</span></p><p style="margin-bottom:2pt; font-size:8pt"><span style="font-weight:bold"></span></p></td><td style="width:228.35pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="font-size:8pt"><span>Clause 4 of the </span><span style="font-style:italic">Food Standards (Application A1230 – Very Low Energy Diets (VLED)) Variation</span><span> provides a transitional arrangement for the variations to the Code made by Item [4.1] of the Schedule to that legislative instrument.</span></p><p style="font-size:8pt"><span></span></p><p style="font-size:8pt"><span>Subclause 4(1) provides that section 1.1.1—9 of the Code</span><span style="font-style:italic"> </span><span>does not apply to the variations made by that instrument.</span></p><p style="font-size:8pt"><span></span></p><p style="font-size:8pt"><span>Subclause 4(2) provides that, during the transition period, a food product may be sold if the product complies with one of the following:</span></p><p style="margin-left:5.65pt; text-indent:-5.65pt; font-size:8pt"><span></span></p><ol class="awlist4" style="margin:0pt; padding-left:0pt"><li style="margin-left:36pt; text-indent:-18pt; font-size:8pt"><span style="width:8.22pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the Code as in force without the variations made by the instrument;</span></li><li style="margin-left:36pt; text-indent:-18pt; font-size:8pt"><span style="width:8.22pt; font:7pt 'Times New Roman'; display:inline-block"></span><span>the Code as amended by the variations made by the instrument.</span></li></ol><p style="margin-left:5.65pt; text-indent:-5.65pt; font-size:8pt"><span></span></p><p style="font-size:8pt"><span>Subclause 4(3) provides that, for the purposes of the above, the transition period is the period commencing on the variation’s date of commencement and ending 36 months after the date of commencement.</span></p><p style="font-size:8pt"><span></span></p><p style="font-size:8pt"><span>This means that </span><span style="font-weight:bold">the transition period is the period of time that commences on 1 June 2022 and ends on 1 June 2025.</span></p><p style="margin-bottom:2pt; font-size:8pt"><span style="font-weight:bold"></span></p></td></tr><tr style="height:14.15pt"><td colspan="5" style="width:444.25pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:middle"><p style="margin-bottom:2pt; font-size:9pt"><span style="font-weight:bold; font-style:italic">Food Standards (Proposal P1028 – Infant Formula Products – Consequential Amendments) Variation</span></p></td></tr><tr><td style="width:41.35pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="font-size:8pt"><span>Items [1] and [2] of Schedule 1</span></p></td><td style="width:27.15pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="margin-left:3.8pt; text-indent:-3.8pt; font-size:8pt"><span>231</span></p></td><td style="width:50pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p class="FSCtblAmendmain"><span style="color:#2d2d31; background-color:#ffffff">F2024L01151</span></p><p class="FSCtblAmendmain"><span>13 Sept 2024</span></p><p class="FSCtblAmendmain"><span>FSC 171</span></p><p style="margin-left:3.8pt; text-indent:-3.8pt; font-size:8pt"><span>13 Sept 2024</span><span></span></p></td><td style="width:57pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p style="margin-left:3.8pt; text-indent:-3.8pt; font-size:8pt"><span>Clause 4</span></p><p style="margin-left:3.8pt; text-indent:-3.8pt; font-size:8pt"><span></span></p></td><td style="width:228.35pt; border-top:1.5pt solid #000000; border-right:0.75pt solid #000000; border-left:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:4.68pt; padding-left:4.68pt; vertical-align:top"><p class="fsctblamendmain0" style="margin-top:0pt; margin-bottom:0pt; font-size:8pt"><span style="font-family:Arial, sans-serif">Clause 4 establishes a transitional arrangement for variations to the Code made by Items [1] and [2] of Schedule 1 and by </span><span style="font-family:Arial, sans-serif; font-style:italic">the Food Standards (Proposal P1028 – Infant Formula Products – Consequential Amendments) Variation.</span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-left:3.8pt; margin-bottom:0pt; text-indent:-3.8pt; font-size:8pt"><span style="font-family:Arial, sans-serif"></span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-bottom:0pt; font-size:8pt"><span style="font-family:Arial, sans-serif; font-weight:bold">The transition period is the period of time that commences on 13 September 2024 and ends on 13 September 2029.</span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-left:3.8pt; margin-bottom:0pt; text-indent:-3.8pt; font-size:8pt"><span style="font-family:Arial, sans-serif"></span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-bottom:0pt; font-size:8pt"><span style="font-family:Arial, sans-serif">Subclause 4(1) provides that section 1.1.1—9 of the Code does not apply to the variations.</span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-left:3.8pt; margin-bottom:0pt; text-indent:-3.8pt; font-size:8pt"><span style="font-family:Arial, sans-serif"></span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-bottom:0pt; font-size:8pt"><span style="font-family:Arial, sans-serif">Subclause 4(2) provides that during the transition period a food product may be sold if the product complies with one of the following:</span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-left:3.8pt; margin-bottom:0pt; text-indent:-3.8pt; font-size:8pt"><span style="font-family:Arial, sans-serif"></span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-left:24.45pt; margin-bottom:0pt; text-indent:-12.2pt; font-size:8pt"><span style="font-family:Arial, sans-serif">(a)</span><span> </span><span style="font-family:Arial, sans-serif">the Code as in force without the above variations;</span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-left:24.45pt; margin-bottom:0pt; text-indent:-12.2pt; font-size:8pt"><span style="font-family:Arial, sans-serif">(b)</span><span> </span><span style="font-family:Arial, sans-serif">the Code as amended by the above variations.</span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-left:3.8pt; margin-bottom:0pt; text-indent:-3.8pt; font-size:8pt"><span style="font-family:Arial, sans-serif"></span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-bottom:0pt; font-size:8pt"><span style="font-family:Arial, sans-serif">Subclause 4(3) provides that a food product that was labelled before the end of the transition period may be sold after the transition period if the product complies with one of the following:</span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-left:3.8pt; margin-bottom:0pt; text-indent:-3.8pt; font-size:8pt"><span style="font-family:Arial, sans-serif"></span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-left:24.45pt; margin-bottom:0pt; text-indent:-12.2pt; font-size:8pt"><span style="font-family:Arial, sans-serif">(a)</span><span> </span><span style="font-family:Arial, sans-serif">the Code as in force without the above variations;</span></p><p class="fsctblamendmain0" style="margin-top:0pt; margin-left:24.45pt; margin-bottom:0pt; text-indent:-12.2pt; font-size:8pt"><span style="font-family:Arial, sans-serif">(b)</span><span> </span><span style="font-family:Arial, sans-serif">the Code as amended by the above variations.</span><br><span></span></p></td></tr></tbody></table>
Amendment History
The Amendment History provides information about each amendment to the Schedule. The information includes commencement or cessation information for relevant amendments.
These amendments are made under section 92 of the Food Standards Australia New Zealand Act 1991 unless otherwise indicated. Amendments do not have a specific date for cessation unless indicated as such.
About this compilation
This is compilation No. 17 of Schedule 29 as in force on 20 January 2026 (up to Amendment No. 247). It includes any commenced amendment affecting the compilation to that date.
Prepared by Food Standards Australia New Zealand on 20 January 2026.
Uncommenced amendments or provisions ceasing to have effect.
To assist stakeholders, the effect of any uncommenced amendments or provisions which will cease to have effect, may be reflected in the Schedule as shaded boxed text with the relevant commencement or cessation date. These amendments will be reflected in a compilation registered on the Federal Register of Legislation including or omitting those amendments and provided in the Amendment History once the date is passed.
The following abbreviations may be used in the table below:
ad = added or inserted am = amended
exp = expired or ceased to have effect rep = repealed
rs = repealed and substituted
Schedule 29 was published in the Food Standards Gazette No. FSC96 on 10 April 2015 as part of Amendment 154 (F2015L00463 –- 1 April 2015) and has since been amended as follows:
Section affected
A’ment No.
FRL registrationGazette
Commencement(Cessation)
How affected
Description of amendment
S29—7
172
F2017L011426 Sept 2017FSC1147 Sept 2017
7 Sept 2017
am
Omit ‘phytylmenoquinone’ from table.
S29—10(3)
157
F2015L013741 Sept 2015FSC993 Sept 2015
1 March 2016
rs
Subsection and related table.
S29—17
161
F2016L0012018 Feb 2016FSC10322 Feb 2016
1 March 2016
am
Correction of typographical error in table heading.
S29—20
168
F2017L0041411 April 2017FSC11013 April 2017
13 April 2017
am
Insertion of a sodium fluoride as a permitted form of fluoride which was inadvertently omitted in FSC96.
Omit L-arginine and substituting L-arginine and L-arginine acetate as a permitted form of Amino acids.
S29—21
161
F2016L0012018 Feb 2016FSC10322 Feb 2016
1 March 2016
rs
Notes 1, 2 and 3 to correct incorrect cross-reference and missing full stops.
S29—21
168
F2017L0041411 April 2017FSC11013 April 2017
13 April 2017
am
Correction to abbreviation of megajoule in the heading,Correction to formatting error for entry for vitamin E.
S29—14
182
F2018L0159423 Nov 2018FSC12329 Nov 2018
29 Nov 2018
am
Corrections to typographical error (1)
S29—14
186
F2019L0099617 July 2019FSC12725 July 2019
25 July 2019
am
Omit L-carnitine 100mg and substitute L‑carnitine 2g
S29—5
198
F2021L0033225 March 2021FSC13926 March 2021
26 March 2021
am
Inserting 2′-O-fucosyllactose and lacto-N-neotetraose
S29—7
200
F2021L006842 June 2021FSC1413 June 2021
3 June 2021
am
Correction of typographical error in table heading.
S29—20
203
F2021L0143114 October 2021FSC14421 October 2021
21 October 2021
am
Omit nicotinic acid and substitute Nicotinamide riboside chloride and nicotinic acid
2.9.1—5
205
F2022L0003818 Jan 2022FSC14620 Jan 2022
20 January 2022
rs
Omit 2′-O-fucosyllactose and substitute 2′-fucosyllactose
S29—22
208
F2022L007331 June 2022FSC 1481 June 2022
1 June 2022
ad
Added section 22For application, saving and transitional provisions, see above table.
S29—5
217
F2023L0045219 April 2023FSC15721 April 2023
21 April 2023
ad
Insert entry for lactoferrin – bovine lactoferrin.
S29—5A
217
F2023L0045219 April 2023FSC15721 April 2023
21 April 2023
ad
Insert section S29—5A
S29—5
223
F2023L0156127 Nov 2023FSC16330 Nov 2023
30 Nov 2023
ad
Insert in table to S29—5 entries for the following substances:3'-sialyllactose sodium salt,6'-sialyllactose sodium salt,a combination of 2′-fucosyllactose with difucosyllactose, andlacto-N-tetraose
S29—2 through to S29—10
231
F2024L0115113 Sept 2024FSC17113 Sept 2024
13 Sept 2024
rs
Repeal sections S29—2 to S29—10 and substitute with new S29—2 to S29—10A
S29—23
231
F2024L0115113 Sept 2024FSC17113 Sept 2024
13 Sept 2024
ad
Insert after section s29—22 new section entry S29—23
S29—20
235
F2025L0016320 Feb 2025FSC 17520 Feb 2025
20 February 2025
ad
Insert new entry for vitamin K
S29—7 through to S29-9A
240
F2025L0085722 July 2025FSC 18022 July 2025
22 July 2025
ad
Insert to tables S29—7, S29—8, S29—9 and S29—9A new entry for milk fat globule membrane-enriched whey protein concentrate
S29—7, S29—8 & S29—9
247
F2026L0002215 January 2026FSC 18720 January 2026
20 January 2026
am
Insert to tables new entry for 3-fucosyllactose permitted for use by Standard 1.5.2